Oxford Nanopore User Group Meeting, Chicago
Overview
Join us to hear local researchers showcasing their work with Oxford Nanopore sequencing and exploring its advantages in future clinical and biopharma research. The agenda also includes technical updates from the Oxford Nanopore team, live Q&A with presenters, hands-on device demonstrations, and a networking reception for registered attendees.
Date: Tuesday, September 29, 2026
Time: 12:30 pm–6:00 pm EDT
Check-in and lunch: 12:30 pm–1:00 pm
Talks: 1:00 pm–5:00 pm
Networking reception: 5:00 pm–6:00 pm
Location: University of Chicago Gleacher Center
Space is limited! Please register early to secure your spot.
Agenda
12:30 pm–06:00 pm CDT | Agenda (subject to change) | Speaker |
|---|---|---|
12:30 pm–01:00 pm | Check-In/Lunch | |
01:00 pm–01:05 pm | Welcome | Gus Potamousis, Oxford Nanopore Technologies |
01:05 pm–01:30 pm | Nanopore updates: The latest and greatest | Maddy Hartley, Oxford Nanopore Technologies |
01:30 pm–02:00 pm | An isoform-centric view of disease through long-read single-cell transcriptomics | Ruli Gao, Northwestern University Feinberg School of Medicine |
02:00 pm–02:30 pm | To follow | Tina de los Reyes, Oxford Nanopore Technologies |
02:30 pm–03:00 pm | To follow | Areej Ammar, AbbVie |
03:00 pm–03:30 pm | Networking Break | |
03:30 pm–04:00 pm | To follow | Brandon Blakey, Oxford Nanopore Technologies |
04:00 pm–04:30 pm | Single-cell long-read sequencing reveals immune cell splicing changes in Alzheimer’s disease | Benney MR Argue, Northwestern University |
04:30 pm–05:00 pm | Resolving chimeric artifacts across Nanopore DNA and RNA sequencing | Qingxiang (Allen) Guo, Northwestern University Feinberg School of Medicine |
05:00 pm–05:05 pm | Closing | Bron Daniel, Oxford Nanopore Technologies |
05:05 pm–06:00 pm | Networking Reception |
Speakers
Gus Potamousis, Oxford Nanopore Technologies
Maddy Hartley, Oxford Nanopore TechnologiesLong-read single-cell RNA sequencing enables direct characterization of full-length transcript isoforms that remain unresolved by conventional short-read approaches. In this talk, I will present our development of Oxford Nanopore Technologies–based experimental and computational methods for high-throughput, isoform-resolved single-cell transcriptomics. Using human tissues, we constructed cell type-specific isoform atlases and identified coordinated changes in isoform usage associated with disease progression. These studies reveal how alternative transcript structures contribute to cellular identity and disease-associated state remodeling beyond changes in gene-expression levels alone. Together, our findings establish long-read single-cell sequencing as a powerful platform for discovering transcript diversity and its functional relevance in human disease.
Long-read single-cell RNA sequencing enables direct characterization of full-length transcript isoforms that remain unresolved by conventional short-read approaches. In this talk, I will present our development of Oxford Nanopore Technologies–based experimental and computational methods for high-throughput, isoform-resolved single-cell transcriptomics. Using human tissues, we constructed cell type-specific isoform atlases and identified coordinated changes in isoform usage associated with disease progression. These studies reveal how alternative transcript structures contribute to cellular identity and disease-associated state remodeling beyond changes in gene-expression levels alone. Together, our findings establish long-read single-cell sequencing as a powerful platform for discovering transcript diversity and its functional relevance in human disease.
Ruli Gao, Northwestern University
Tina de los Reyes, Oxford Nanopore Technologies
Areej Ammar, AbbVie
Brandon Blakey, Oxford Nanopore TechnologiesIn this clinical research study we performed single-cell long-read sequencing on immune cells from cerebrospinal fluid (CSF) and blood to assess isoform diversity in healthy aging individuals and those diagnosed with mild cognitive impairment (MCI) or Alzheimer’s disease (AD). cDNA from single-cell experiments was subjected to long-read sequencing using Oxford Nanopore Technologies. The dataset included immune cells from CSF (45 controls, 13 MCI/AD) and blood (22 controls, 28 AD). Computational analysis incorporated scNanoGPS for extracting cell barcodes and mapping reads to the genome, IsoQuant for isoform modeling, SQANTI3 for filtering artifacts, Hypatia for differential transcript usage (DTU) analysis, and ScIsoX for assessing isoform diversity. We identified 97,920 unique transcripts in CSF and 139,351 in blood. Approximately half of expressed genes in both compartments were expressed through multiple isoforms, and 20% of detected isoforms were previously unannotated in the human genome. In the CSF, several AD risk genes - including APOC1 and MS4A6A - expressed multiple isoforms within single cells, suggesting complex isoform-level regulation in immune populations. DTU analysis revealed significant splicing shifts in CSF-derived monocytes of individuals with cognitive impairment. We conclude that human immune cells demonstrate extensive isoform diversity, including previously unannotated isoforms, particularly in genes implicated in AD. Disease-associated splicing changes suggest that isoform-level regulation may contribute to immune dysfunction in AD.
In this clinical research study we performed single-cell long-read sequencing on immune cells from cerebrospinal fluid (CSF) and blood to assess isoform diversity in healthy aging individuals and those diagnosed with mild cognitive impairment (MCI) or Alzheimer’s disease (AD). cDNA from single-cell experiments was subjected to long-read sequencing using Oxford Nanopore Technologies. The dataset included immune cells from CSF (45 controls, 13 MCI/AD) and blood (22 controls, 28 AD). Computational analysis incorporated scNanoGPS for extracting cell barcodes and mapping reads to the genome, IsoQuant for isoform modeling, SQANTI3 for filtering artifacts, Hypatia for differential transcript usage (DTU) analysis, and ScIsoX for assessing isoform diversity. We identified 97,920 unique transcripts in CSF and 139,351 in blood. Approximately half of expressed genes in both compartments were expressed through multiple isoforms, and 20% of detected isoforms were previously unannotated in the human genome. In the CSF, several AD risk genes - including APOC1 and MS4A6A - expressed multiple isoforms within single cells, suggesting complex isoform-level regulation in immune populations. DTU analysis revealed significant splicing shifts in CSF-derived monocytes of individuals with cognitive impairment. We conclude that human immune cells demonstrate extensive isoform diversity, including previously unannotated isoforms, particularly in genes implicated in AD. Disease-associated splicing changes suggest that isoform-level regulation may contribute to immune dysfunction in AD.
Benny MR Argue, Northwestern University Nanopore sequencing provides long-range genomic and transcriptomic information, but technical chimeras can create junctions that closely resemble genuine structural variants or transcript rearrangements. We have encountered this problem in several nanopore DNA and RNA sequencing workflows, where similar-looking read structures can arise through very different mechanisms.
In direct RNA sequencing, internal adapters can join otherwise unrelated RNA fragments and are difficult to recognize after basecalling. DeepChopper uses a genomic language model to identify these adapter sequences at nucleotide resolution and resolve the resulting chimeric reads. In direct-cDNA sequencing, the artifact landscape is broader because reverse transcription can generate foldback inversions, internal adapter chimeras, and homopolymer-mediated template switching. DirectClean was developed to detect these events while rescuing usable sequence for downstream transcriptome analysis. A related challenge occurs in whole-genome-amplified long-read DNA data, where amplification can generate chimeric reads that mimic structural variants. ChimeraLM uses matched WGA and bulk sequencing to distinguish these artifacts from genuine genomic events, while OctopuSV is used to harmonize and compare structural variant calls for downstream evaluation.
Across these projects, the common goal is to remove technical junctions without losing the long-range information that makes nanopore sequencing valuable for genomic and transcriptomic analysis.
Nanopore sequencing provides long-range genomic and transcriptomic information, but technical chimeras can create junctions that closely resemble genuine structural variants or transcript rearrangements. We have encountered this problem in several nanopore DNA and RNA sequencing workflows, where similar-looking read structures can arise through very different mechanisms.
In direct RNA sequencing, internal adapters can join otherwise unrelated RNA fragments and are difficult to recognize after basecalling. DeepChopper uses a genomic language model to identify these adapter sequences at nucleotide resolution and resolve the resulting chimeric reads. In direct-cDNA sequencing, the artifact landscape is broader because reverse transcription can generate foldback inversions, internal adapter chimeras, and homopolymer-mediated template switching. DirectClean was developed to detect these events while rescuing usable sequence for downstream transcriptome analysis. A related challenge occurs in whole-genome-amplified long-read DNA data, where amplification can generate chimeric reads that mimic structural variants. ChimeraLM uses matched WGA and bulk sequencing to distinguish these artifacts from genuine genomic events, while OctopuSV is used to harmonize and compare structural variant calls for downstream evaluation.
Across these projects, the common goal is to remove technical junctions without losing the long-range information that makes nanopore sequencing valuable for genomic and transcriptomic analysis.
Qingxiang (Allen) Guo, Northwestern University Feinberg School of Medicine
)